Vascular Cures is located in Redwood City, CA. The organization was established in 1982. According to its NTEE Classification (H43) the organization is classified as: Heart & Circulatory System Diseases & Disorders Research, under the broad grouping of Medical Research and related organizations. As of 06/2022, Vascular Cures employed 6 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Vascular Cures is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Vascular Cures generated $2.2m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 30.8% each year . All expenses for the organization totaled $2.1m during the year ending 06/2022. While expenses have increased by 11.8% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2017, Vascular Cures has awarded 26 individual grants totaling $1,323,136. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
OUR MISSION IS TO AMPLIFY THE PATIENT VOICE, ACCELERATE PATIENT-CENTERED RESEARCH, AND CATALYZE INNOVATIVE COLLABORATIONS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
WE SERVE AS THE FISCAL SPONSOR OF AMERICAN LIMB PRESERVATION SOCIETY. WHEN WE LAUNCHED PROJECT VOICE, IT WAS THE FIRST DIGITAL HEALTH PROGRAM TO IMPROVEOUTCOMES FOR PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD). PROJECT VOICE WILL 1)BRING PATIENTS INTO THE HEALTHCARE CONVERSATION, MANAGE THEIR OWN HEALTH AND SHAREIN DECISION-MAKING; 2) ENABLE RESEARCHERS TO GATHER PATIENT-REPORTED OUTCOMES DATA,CURRENTLY A CRUCIAL GAP IN BOTH RESEARCH AND HEALTHCARE AND 3) IMPROVEPATIENT-PHYSICIAN PARTNERSHIPS THROUGH HIGHER QUALITY INFORMATION EXCHANGE ANDSHARED DECISION-MAKING. THE ULTIMATE GOAL IS TO IMPROVE OUTCOMES AND LOWERHEALTHCARE COSTS.
EDUCATION AND COMMUNITY AWARENESS PROGRAMS ARE THE AWARENESS OF THE RISKS, CONSEQUENCES AND NEW TREATMENTS FOR VASCULAR DISEASE. WE EMPHASIZE EMPOWERMENT AND SHARED DECISION-MAKING BEST PRACTICES, HELPING TO ENSURE THAT PATIENTS WITH VASCULAR DISEASE AND THEIR FAMILIES ARE EQUIPPED WITH THE KNOWLEDGE TO MAKE INFORMED DECISIONS ABOUT THEIR HEALTH CARE. WE HAVE A SPECIFIC FOCUS ON PREVENTION AND MAKING RESOURCES ACCESSIBLE TO VULNERABLE POPULATIONS AND COMMUNITIES. EVERY YEAR, MORE THAN 200,000 INDIVIDUALS AROUND THE WORLD VISIT OUR WEBSITE TO LEARN ABOUT VASCULAR DISEASE AND CONNECT TO CRITICAL RESOURCES.(CONTINUED ON SCHEDULE O)
THE WYLIE SCHOLAR PROGRAM PROVIDES 3-YEAR CAREER DEVELOPMENT GRANTS TO OUTSTANDING YOUNG VASCULAR SURGEON-SCIENTISTS WHO COMBINE ACTIVE PATIENT CARE WITH ACADEMIC RESEARCH. THE AWARD SUPPORTS CRUCIAL RESEARCH THAT ENABLES THEM TO COMPETE FOR FUTURE RESEARCH FUNDING. WYLIE SCHOLARS BECOME NORTH AMERICAS WORLD-CLASS VASCULAR SURGEON-SCIENTISTS; MANY ARE NOW CHIEFS AT MAJOR ACADEMIC CENTERS, PROMINENT LEADERS IN THE FIELD, AND PLAY A KEY ROLE IN OUR PROGRAMS. SINCE 1996, WEVE SUPPORTED 24 SURGEON-SCIENTISTS AT 15 INSTITUTIONS AROUND THE COUNTRY WHO ARE TRANSFORMING PATIENT CARE. THE AVERAGE RETURN ON INVESTMENT FOR FOLLOW-ON RESEARCH FUNDING IS 30:1.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Megan Patterson CEO | OfficerTrustee | 40 | $136,250 |
Lenimfa Catalan Staff | 40 | $100,000 | |
Edward Yu Board Chair | OfficerTrustee | 2 | $0 |
David Rae Treasurer | OfficerTrustee | 2 | $0 |
Michael Conte MD Cmo | Trustee | 2 | $0 |
Lilia Martinez-Coburn Director | Trustee | 2 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $1,313,014 |
Noncash contributions included in lines 1a–1f | $20,228 |
Total Revenue from Contributions, Gifts, Grants & Similar | $1,313,014 |
Total Program Service Revenue | $648,666 |
Investment income | $121,981 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $69,791 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $2,153,452 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $320,267 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $100,000 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $136,250 |
Compensation of current officers, directors, key employees. | $11,980 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $303,542 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $28,991 |
Payroll taxes | $31,507 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $38,633 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $17,405 |
Fees for services: Other | $230,179 |
Advertising and promotion | $9,355 |
Office expenses | $76 |
Information technology | $16,887 |
Royalties | $0 |
Occupancy | $0 |
Travel | $13,477 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $577 |
Insurance | $6,150 |
All other expenses | $11,947 |
Total functional expenses | $2,056,902 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $853,875 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $368,021 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $1,155 |
Investments—publicly traded securities | $0 |
Investments—other securities | $2,564,392 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $3,787,443 |
Accounts payable and accrued expenses | $152,865 |
Grants payable | $0 |
Deferred revenue | $138,500 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $192,108 |
Total liabilities | $483,473 |
Net assets without donor restrictions | $557,205 |
Net assets with donor restrictions | $2,746,765 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $3,787,443 |
Over the last fiscal year, Vascular Cures has awarded $325,400 in support to 7 organizations.
Grant Recipient | Amount |
---|---|
CASA COLINA HOSPITAL CENTERS PURPOSE: Research | $50,000 |
UNIVERSITY OF FLORIDA PURPOSE: Research | $39,000 |
UNIVERSITY OF MASSACHUSETTS PURPOSE: Research | $50,000 |
DUKE UNIVERSITY PURPOSE: Research | $100,000 |
UNIVERSITY OF MICHIGAN PURPOSE: Research | $50,000 |
UNIVERSITY OF PITTSBURGH PURPOSE: Research | $30,800 |